Corvus Pharmaceuticals Appoints David Moore to Board of Directors - Corvus Pharma (NASDAQ:CRVS)

Corvus Pharmaceuticals Appoints David Moore to Board of Directors - Corvus Pharma (NASDAQ:CRVS)

SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, announced today that David Moore, Executive Vice President, US Operations at Novo Nordisk A/S and President at Novo Nordisk Inc., has been appointed to the company's Board of Directors. Mr. Moore brings a wealth of experience from his 27-year career in the industry, including broad expertise acros…